Ophthalmic Drug Delivery
ONdrugDelivery
The Global Innovation and Development team of Phillips-Medisize, a Molex company, considers the approach to developing a novel drug delivery device for age-related macular degeneration. Read the article published in ONdrugDelivery to learn how to work through ideation, assess user needs, investigate feasibility and more to approach drug delivery approaches for the eye.
March 2022 | Issue No 130 | Page 50-52